SKINSPECTION

MULTIMODAL SKIN INSPECTION WITH HYBRID ACOUSTIC & OPTICAL SPECTROSCOPIC IMAGING

 Coordinatore FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V 

 Organization address address: Hansastrasse 27C
city: MUENCHEN
postcode: 80686

contact info
Titolo: Ms.
Nome: Andrea
Cognome: Zeumann
Email: send email
Telefono: -3968
Fax: -8779

 Nazionalità Coordinatore Germany [DE]
 Totale costo 5˙232˙072 €
 EC contributo 4˙097˙585 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2007-A
 Funding Scheme CP-FP
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-04-01   -   2012-03-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V

 Organization address address: Hansastrasse 27C
city: MUENCHEN
postcode: 80686

contact info
Titolo: Ms.
Nome: Andrea
Cognome: Zeumann
Email: send email
Telefono: -3968
Fax: -8779

DE (MUENCHEN) coordinator 0.00
2    IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

 Organization address address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ

contact info
Titolo: Ms.
Nome: Brooke
Cognome: Alasya
Email: send email
Telefono: -75941157
Fax: -75941395

UK (LONDON) participant 0.00
3    JENLAB GMBH

 Organization address address: Nerkewitzer Strasse 18
city: NEUENGOENA
postcode: 7778

contact info
Titolo: Prof.
Nome: Karsten
Cognome: Koenig
Email: send email
Telefono: -3136788
Fax: -474135

DE (NEUENGOENA) participant 0.00
4    KIBERO

 Organization address address: BISMARCKSTRASSE 56
city: SAARBRUECKEN
postcode: 66121

contact info
Titolo: Mr.
Nome: Eike Christian
Cognome: Weiss
Email: send email
Telefono: +49 179 5322703
Fax: +49 721 151 284 216

DE (SAARBRUECKEN) participant 0.00
5    TP21 GMBH

 Organization address address: LUISENSTRASSE 14
city: BERLIN
postcode: 10117

contact info
Titolo: Dr.
Nome: Petra
Cognome: Zalud
Email: send email
Telefono: -3907351
Fax: -3907352

DE (BERLIN) participant 0.00
6    UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA

 Organization address address: VIA UNIVERSITA 4
city: MODENA
postcode: 41100

contact info
Titolo: Prof.
Nome: Alberto
Cognome: Giannetti
Email: send email
Telefono: -4224284
Fax: -4224291

IT (MODENA) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

lifetime    us    melanoma    imaging    skin    women    multimodal    resolution    sun    people    quantitative    cancer    treatment    health    diagnostic    photon    improvement    invasive   

 Obiettivo del progetto (Objective)

'The incidence of skin cancer in Europe, US, and Australia is rising rapidly. One in five will develop some form of skin cancer during the lifetime. A person has a 1:33 chance to develop melanoma, the most aggressive skin cancer. Melanoma is the second most common cancer in women aged 20-29, and the sixth most common cancer in men and women. In 2007, more than 1 million new cases will be diagnosed in the US alone. About 90% of skin cancers are caused by ultraviolet (UV) sun light. The World Health Organization estimates that 60,000 people will die this year from too much sun: 48,000 from melanoma and 12,000 from other skin cancer. A significant improvement of the current diagnostic tools of dermatologists is required in order to identify dermal disorders at a very early stage as well as to monitor directly the effects of treatment. We suggest within this proposal the development of a non-invasive multimodal hybrid imaging system with the capability to perform non-invasive high resolution three-dimensional clinical (i) two-photon imaging with time-correlated single photon detection, (ii) autofluorescence lifetime imaging, (iii) high-frequency acoustical imaging with novel miniaturized multiple detector arrays, and (iv) optoacoustical imaging using ultrashort near infrared (NIR) laser pulses. This novel multimodal approach will provide a wide-field “acoustic/optoacoustic” view with quantitative depth information of the dermatological lesion as well as a close “optical” look into particular intratissue compartments with quantitative hyperspectral information and subcellular resolution. A successful project will provide a novel unique tool for early diagnosis and treatment control of skin cancer and skin disease and will significantly contribute to the improvement of the European health care system.'

Introduzione (Teaser)

One in five people in developed countries will develop skin cancer. This alarming statistic necessitates novel, highly sensitive diagnostic methods.

Altri progetti dello stesso programma (FP7-HEALTH)

STRONG (2012)

European Consortium for the Study of a Topical Treatment of Neovascular Glaucoma

Read More  

NRT (2012)

Phase II clinical trial of PDGF-BB for the neurological regeneration and recovery in Parkinson´s disease

Read More  

EURO-TEAM (2012)

Towards Early diagnosis and biomarker validation in Arthritis Management

Read More